ArchiMed-backed NAMSA acquires American Preclinical Services

NAMSA, which is backed by ArchiMed, has acquired American Preclinical Services, a provider of medical device and pharmaceutical testing.

2 March 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles